A heart-team hybrid approach for atrial fibrillation: a single-centre long-term clinical outcome cohort study.
Gansevoort H DunningtonCarrie L PierceSusan EisenbergLiem L BingPeter Chang-SingDaniel W KaiserShelby BurkLinda C MoultonArmin KiankhooyPublished in: European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery (2022)
A heart-team hybrid strategy for the treatment of AF is safe and effective. In a predominantly non-paroxysmal population with AF, at the 3-year follow-up, FFAF in patients on and off anti-arrhythmic drugs approaches that of patients who had the Cox-maze IV.
Keyphrases
- atrial fibrillation
- catheter ablation
- left atrial
- oral anticoagulants
- heart failure
- end stage renal disease
- left atrial appendage
- direct oral anticoagulants
- palliative care
- ejection fraction
- chronic kidney disease
- newly diagnosed
- quality improvement
- prognostic factors
- percutaneous coronary intervention
- patient reported outcomes
- african american
- coronary artery disease
- left ventricular